HealthTimes

Donald Trump speaking at a podium, representing US government leadership on international health agreements
Africa HIV/AIDS

Leaked Memo Shows U.S. May Cut HIV Aid to Zambia to Secure Mineral Access

Michael Gwarisa

Michael Gwarisa A report in The New York Times reveals that the U.S. State Department is considering a significant reduction in health assistance to Zambia as a negotiating tool to gain greater access to the country’s critical minerals. According to The New York Times, a draft memo prepared for Secretary of State Marco Rubio suggests

Read More
Zimbabwe Wraps Up Japan-Supported Hospital Quality Drive with Improved Patient Outcomes
Breaking News Health News

Zimbabwe Wraps Up Japan-Supported Kaizen Programme, Reporting Improved Hospital Patient Outcomes

Kuda Pembere

  Kuda Pembere A nationwide hospital quality improvement programme, Kaizen, has concluded after four years, with the Health and Child Care Ministry reporting improvements in hospital organisation, service delivery and patient satisfaction. The 5S-Kaizen Total Quality Management (TQM) initiative, which ran from 2022 to 2025, was supported by the Japan International Cooperation Agency (JICA) in

Read More
Participants from several African countries attend the Africa CDC Mental Health Leadership short course hosted in Zimbabwe.
Health News Features MENTAL HEALTH

Africa CDC Trains Diverse Leaders to Close Africa’s Mental Health Treatment Gap

Michael Gwarisa

WATCH: Africa CDC Trains New Leaders to Close Africa’s Mental Health Treatment Gap https://www.youtube.com/watch?v=RW1XAFxxtVE&t=34s Michael Gwarisa In 2015, Pamhidzai-Violet Togara lost her job. A few months later, her marriage collapsed, pushing her into a severe mental health crisis. “My husband took another wife soon after I lost my job. He told me to take it

Read More
Dr Douglass Mombeshora, Zimbabwe’s Minister of Health and Child Care, cutting the ribbon to officially launch Lenacapavir, a long-acting injectable HIV prevention drug.
Africa Health News HIV/AIDS

Rare HIV ‘Breakthrough’ Cases Reported in Lenacapavir PrEP Trials Across Africa

Michael Gwarisa

Michael Gwarisa As more African countries begin to introduce lenacapavir into their HIV prevention programmes, scientists are examining new data showing that a small number of people became infected with HIV while using the medication. The drug’s rollout now extends beyond just one or two nations. Countries that have started distributing the twice-yearly injectable or

Read More
Portrait of Dr Evelyn Mazire, the late Zimbabwean mental health expert honoured with a training course named after her by the University of Zimbabwe and Africa CDC.
Health News

Africa CDC, UZ Honour Zimbabwe’s Dr Evelyn Mazike With Named Mental Health Short Course

Michael Gwarisa

Watch: Honoring a Legend: The Dr. Evelyn Masike Zimbabwe Mental Health Leadership Course https://www.youtube.com/watch?v=0LA_2HsML5Y Michael Gwarisa The University of Zimbabwe, in collaboration with the Africa CDC, has named the Zimbabwe Mental Health Leadership Short Course after the late psychiatrist Dr Evelyn Mazike. Dr Mazike, a lecturer in the Department of Mental Health at the University

Read More
Black hand holding a lenacapavir injection and medicine vial symbolising HIV prevention and South Africa’s plan to locally manufacture the long-acting HIV drug.
Africa Health News HIV/AIDS

South Africa Urged to Secure Better Lenacapavir License Terms With Gilead Before Local Manufacturing

Michael Gwarisa

Michael Gwarisa Doctors Without Borders (MSF) has urged South Africa not to rush into local manufacturing of lenacapavir, an injectable HIV prevention drug, without first negotiating stronger, more equitable license terms or using a compulsory license to bypass patent restrictions. Their call follows a recent announcement by the South African government that it is negotiating

Read More
Illustration of a human head filled with mental health struggles including depression, anxiety, poverty, debt, loneliness, addiction, and unpaid bills symbolizing the burden of mental illness.
Health News Global Health MENTAL HEALTH

New Global Research Grants Open for Mental Health Nurse Practitioners to Study Schizophrenia and Bipolar Disorder

Michael Gwarisa

Michael Gwarisa Pharmaceutical company Alkermes plc has unveiled a new research funding initiative aimed at supporting psychiatric nurse practitioners who are working to improve treatment for serious mental health conditions. The company announced that applications for the first Alkermes Pathways APN Research Awards™ will officially open on March 16, 2026, offering funding opportunities to advanced

Read More
IMG 20260306 WA00091
Health News MARTERNAL HEALTH Maternal & Reproductive Health

Zimbabwe Expands Fistula Repair Camps as Thousands of Women Await Surgery

Kuda Pembere

Kuda Pembere Fewer than 2 000 women and adolescent girls in Zimbabwe have received corrective surgery for obstetric fistula since specialised repair camps began in 2014, prompting health authorities to expand the programme nationwide to tackle a backlog of thousands living with the preventable childbirth injury. According to the Zimbabwe Health Demographic Survey (2023-24), about

Read More
Nurses gather at ZINA organized meeting
Health News

Mystery Donor Payments Spark Rift Among Nurses at Central Hospitals

Kuda Pembere

Kuda Pembere A rift has emerged among nurses at Zimbabwe’s central hospitals after an unidentified donor began paying nursing tutors and instructors, leaving out registered general nurses and midwives who say they do most of the mentoring for student nurses in clinical areas. Zimbabwe Nurses Association (ZINA) Secretary General at Sally Mugabe Central Hospital, Farai

Read More
A close-up of a white hand holding a single white pill between the thumb and index finger against a blurred green background.
Global Health Health News HIV/AIDS

New Single-Pill HIV Treatments Show Strong Results in Global Trials

Michael Gwarisa

Michael Gwarisa Two new once-daily HIV treatments taken as a single pill have shown strong results in late-stage clinical trials, raising hopes for simpler treatment options for people living with the virus. The studies were presented at the Conference on Retroviruses and Opportunistic Infections 2026 in Denver, United States. Researchers tested whether the new drugs

Read More